RIVERNORTH CAPITAL MANAGEMENT, LLC 13D and 13G filings for Bellevue Life Sciences Acquisition Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-01-10 3:56 pm Sale |
2024-12-31 | 13G | Bellevue Life Sciences Acquisition Corp. BLAC |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 0 0.000% |
-245,115![]() (Position Closed) |
Filing |
2024-11-14 4:47 pm Purchase |
2024-09-30 | 13G | Bellevue Life Sciences Acquisition Corp. BLAC |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 245,115 6.070% |
245,115![]() (New Position) |
Filing |